Related Experiment Video
Updated: Jun 24, 2025

06:48
An Orthotopic Murine Model of Human Prostate Cancer Metastasis
Published on: September 18, 2013
35.1K
Genistein: A promising phytoconstituent with reference to its bioactivities
Vaishnavi Shete1, Nilesh M Mahajan2, Ruchi Shivhare2
1Department of Pharmaceutics, Datta Meghe College of Pharmacy, Wardha, Maharashtra, India.
Phytotherapy Research : PTR
|June 4, 2024
Summary
Genistein, a plant compound, shows antioxidant and anticancer effects by influencing cell pathways. This review explores its properties, therapeutic uses in cancer, and mechanisms of action.
Area of Science:
- Biochemistry
- Pharmacology
- Molecular Biology
Background:
- Genistein is a significant phytoconstituent with diverse bioactivities.
- It has garnered substantial research interest due to its potential health benefits.
- Its interaction with cellular pathways and molecular targets is a key area of study.
Purpose of the Study:
- To provide a comprehensive review of genistein.
- To examine its antioxidant and anticancer potential.
- To explore its therapeutic applications and mechanisms of action in disease management.
Main Methods:
- Literature review of existing research on genistein.
- Analysis of studies on genistein's chemical properties, isolation, and synthesis.
- Examination of research on its biological activities and proposed mechanisms.
Main Results:
- Genistein exhibits significant antioxidant and anticancer properties.
- It modulates various cellular pathways and interacts with multiple molecular targets.
- Evidence suggests its potential role in disease prevention and treatment, particularly in cancer management.
Conclusions:
- Genistein is a promising phytoconstituent with broad therapeutic potential.
- Further research into its mechanisms and applications is warranted.
- Its multifaceted properties make it a valuable subject for continued scientific exploration.
More Related Videos
Related Concept Videos
In-vitro Mutagenesis
13.9K
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
13.9K
Cancer-Critical Genes I: Proto-oncogenes
8.8K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.8K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
Loss of Tumor Suppressor Gene Functions
4.8K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
4.8K
Mutagenicity and Carcinogenicity
1.2K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.2K
Cancer-Critical Genes II: Tumor Suppressor Genes
7.4K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.4K

